首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1186610

醫用大麻市場：分析與預測 (2022-2028)

Medical Marijuana Market: Current Analysis and Forecast (2022-2028)

出版日期: 2022年12月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

從 2022 年到 2028 年，全球醫用大麻市場規模預計將以約 21% 的複合年增長率增長。

市場的增長主要是由於其在阿爾茨海默病、癌症和精神分裂症等疾病治療領域的應用不斷擴大。通過應用，慢性疼痛領域將在 2020 年佔據大部分市場份額。這主要是由於疼痛、癌症、關節炎和中風的治療越來越普遍。此外，按類型劃分，油和酊劑部分預計在預測期內的複合年增長率最高。

本報告調查了全球醫用大麻市場，定義和概述了市場，分析了影響市場增長、變化和市場規模預測的各種因素，總結了細分、法律和監管環境、供需趨勢、競爭環境, 主要公司概況等

內容

第一章介紹

第二章調查方法及前提條件

第 3 章市場概述

第 4 章執行摘要

第 5 章 COVID-19：對醫用大麻市場的影響

第 6 章醫用大麻市場：收益趨勢和預測

第 7 章市場洞察：按應用

慢性疼痛
關節炎
偏頭痛
癌症
其他

第 8 章市場洞察：按類型

花
油和酊劑
可食用
其他

第 9 章市場洞察：按分銷渠道

醫務室
在線渠道
其他

第 10 章市場洞察：按地區

北美
歐洲
亞太地區
其他地區

第 11 章醫用大麻市場：市場動態

市場驅動力
市場問題
影響分析

第 12 章醫用大麻市場：市場機會

第 13 章醫用大麻市場：市場趨勢

第 14 章政策和監管框架

第15章需求側與供給側分析

需求方分析
供應方分析

第 16 章價值鏈分析

第 17 章衝突場景

第十八章公司簡介

Canopy Growth Corporation
CANNABIS SATIVA, INC
GW Pharmaceuticals plc.
Emerald Health Therapeutics Inc.
Tilray.
Aphria Inc
Aurora Cannabis
CARA THERAPEUTICS, INC
Medical Marijuana, Inc
Pfizer Inc.

第19章免責事項

簡介目錄

Product Code: UMME211421

The global medical marijuana market is experiencing significant growth due to the increased number of patients suffering from chronic diseases like Epilepsy, Crohn's disease, and Alzheimer's disease and awareness regarding this has also fueled the growth of the medical marijuana market. For instance, Aurora Cannabis, in August 2019, successfully acquired Hempco Food and Fiber Inc., to gain access to cost-effective hemp, to extract cannabidiol (CBD). Similarly, Aphria acquired CC Pharma, which provides numerous pharmaceutical products, such as cannabis, in Germany and other European countries, in January 2019. Cannabidiol (CBD) is a medical benefit associated with the plant are anticipated to boost product demand. Thus, it works by helping to restore the balance to have several medicinal benefits. For instance, epidiolex is a CBD oil extract that is currently undergoing clinical trials for epilepsy. Furthermore, epilepsy is one of the most common neurological diseases globally. Therefore, the market for medical marijuana is expected to witness a significant CAGR of ~21% during the forecast period.

Global medical marijuana market is expected to register a CAGR of around ~21% over the period of 2022-2028. This is mainly due to its increasing application in the therapeutic field for the treatment of such disorders as Alzheimer's disease, cancer, and schizophrenia. It is derived from the Cannabis sativa plant, which can be used for the treatment of chronic diseases and pain management. Medical marijuana has stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make medical marijuana products more sustainable with fewer side effects and cost-effective. Major healthcare companies are investing heavily in their products due to rising social awareness regarding chronic pain disorder cases, and other associated disorders, such as mania, anxiety, cancer, and treatment of seizures. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20 percent, have some form of chronic pain. This rise in the demand for cannabis in medical is contributing to market growth. Furthermore, various factors such as growing research and development activities are also expected to drive the demand for the drug over the forecast period which is responsible for excessive use of medical marijuana and also significantly contributes to the market for meditation for the treatment of a health condition. As a result, the government is focusing on raising awareness about the illnesses and the effect which significantly contributes to the market for medical marijuana. Therefore, the market for medical marijuana is expected to witness significant growth during the forecast period

Canopy Growth Corporation, Cannabis Sativa, Inc, GW Pharmaceuticals plc., Emerald Health Therapeutics Inc., Tilray, Aphria Inc, Aurora Cannabis, Cara Therapeutics, Medical Marijuana, and Pfizer Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Application, chronic pain category accounted for the majority share in the market in 2020"

Based on application, the market is classified into chronic pain, arthritis, migraine, cancer, and others. The chronic pain category accounted for a significant share of the market. This is mainly due to the use of medical marijuana in the treatment of the increasing prevalence of pain, cancer, arthritis, and treatment of seizures in the global markets. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20 percent, have some form of chronic pain. Over the forthcoming years, the rising application in the therapeutic field is likely to boost the demand for medical marijuana.

"Amongst Type, Oil and Tinctures are expected to witness highest CAGR during the forecast period"

Based on product, the market is categorized into flowers, oil and tinctures, edibles, and others. Among these, Oil and Tinctures are expected to witness the highest CAGR during the forecast period. This is mainly due to the strong prevalence of medical ability in the treatment of various health conditions and governments of many countries are either legalizing or approving it for medicinal use. Marijuana oils are preferred as they are a blend of cannabis extracts and inert carrier oils. The oils are easier to find and are expected to support the growth of the segment over the forecast period. These results boost the production of medical marijuana the continuous development of the new products and treatments is likely to strengthen the market of the segment during the forecast period

"North America to witness significant growth during the forecast period"

North America is expected to show the highest CAGR growth in the medical marijuana market. The major contributors to the growth of this market are US and Canada. This is mainly due to the growing various medical marijuana and therapeutic uses of marijuana products as well as the potential impact of marijuana legalization on the U.S. economy. For instance, in February 2020, Verda Innovations, a medical cannabis-based company in the U.S. announced the launch of its legal cannabis e-commerce and delivery platform in Canada, and U.S. Launch of such online platforms is considered to be one of the major factors expanding growth. Thus, increase in the number of countries legalizing it and an increase in the number of prescriptions filled for medicinal marijuana biopharmaceutical companies and diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global medical marijuana market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Medical Marijuana Market
2.2. Research Methodology of the Medical Marijuana Market
2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL MEDICAL MARIJUANA MARKET COVID-19 IMPACT

6 GLOBAL MEDICAL MARIJUANA MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY APPLICATION

7.1. Chronic Pain
7.2. Arthritis
7.3. Migraine
7.4. Cancer
7.5. Others

8 MARKET INSIGHTS BY TYPE

8.1. Flowers
8.2. Oil and Tinctures
8.3. Edibles
8.4. Others

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

9.1. Dispensaries
9.2. Online Channel
9.3. Others

10 MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. UK
- 10.2.3. France
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Australia
- 10.3.5. Rest of Asia-Pacific
10.4. Rest of World